Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01568619 · ClinicalTrials.gov registry record
Validation of Electrical Cardiometry Versus Fick Method in Cardiac Output Measurement
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 30
- Enrollment target
NCT01568619: Completed study, sponsored by Massachusetts General Hospital.
NCT01568619 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01568619 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The investigators would like to find out if AESCULON®, a new device that non-invasively and continuously measures cardiac output using electrical cardiometry, works as well as one existing method--Fick method in patients undergoing cardiopulmonary exercise testing.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2012-03 |
| Est. Completion | 2015-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01568619
The ClinicalTrials.gov registry entry for NCT01568619 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01568619 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01568619 about?
NCT01568619 is a clinical study titled "Validation of Electrical Cardiometry Versus Fick Method in Cardiac Output Measurement". The investigators would like to find out if AESCULON®, a new device that non-invasively and continuously measures cardiac output using electrical cardiometry, works as well as one existing method--Fick method in patients undergoing cardiopulmonary exercise testing.
What is the current status of trial NCT01568619?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2012-03. Estimated completion is 2015-10.
Who is sponsoring clinical trial NCT01568619?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.